22.02.2024 - Continued Focus on Expanding Product Portfolio, Market Leadership and InnovationSAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) - Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to .
Form N-CSRS Federated Hermes High For: Aug 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The following discussion and analysis of financial condition and results of
operations should be read together with our audited consolidated financial
statements and the related notes included under. | March 24, 2023
22.02.2023 - Base business revenues, excluding COVID-19 related CleanCap revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilities to .
04.08.2022 - Record First Half Revenue, EBITDA, Adjusted EBITDA and EPSSAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) - Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech .